Feed 300683.SZ
30
Wuhan Hiteck Biological Pharma Co.,Ltd
300683.SZ · SHZ
¥28.98 -4.80% (-¥1.46)
1M +11.14%
Market Cap ¥3.79B
P/E Ratio -
Div. Yield -
ROE 10.82%
Bulios Fair Price
¥21.92
24.4% downside
Current Price
¥28.98
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 300683.SZ is currently overvalued relative to its market price. How does it work?
Piotroski F-Score Weak
2/9Valuation
54 /100
Fair P/B 1.77x
P/S 6.97x
P/FFO N/A
Growth
3 /100
Declining Book val. growth 2.21%
Rev. growth 7.70%
FCF growth N/A
Profitability
16 /100
Weak Net margin 44.20%
Op. margin 45.13%
FCF margin 14.30%
Quality
3 /100
Poor ROE 10.82%
ROA 9.45%
Asset turnover 0.21x
Debt
69 /100
Low Current ratio 4.17x
Int. coverage -201.30x
Debt/Equity 0.01x
Stability
37 /100
Moderate Rev. volatility 13.03%
EPS volatility 400.00%
Profitable years 0
Ask StockBot about 300683.SZ
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Wen Xian
Employees
958
Headquarters
Wuhan